Social Media Newsroom


Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases, including monoclonal antibodies for treating COVID-19 and HIV, and anti-cancer therapeutics.


Press Contact

Robert Grant

Press Releases

Enzolytics Will Promote its Nutritional Supplement at ECRM Event Next Week

More Released on September 8, 2022

Enzolytics Inc.: A Texas-Based Biotech Company Dedicated to Developing Therapeutics to Treat Infectious Diseases

More Released on May 20, 2022

Enzolytics CEO: Immune Modulator Stimulates the Immune System

More Released on April 29, 2022

Enzolytics CEO: Immune Health Supplements Market Expected to Increase by 9 Percent Annually Through 2031

More Released on April 21, 2022

Enzolytics, Inc. Continues Product Launch of Immune Modulator After Meeting With Retailers

More Released on April 19, 2022 Will Soon Offer Enzolytics IPF Immune™

More Released on April 11, 2022

CEO of Enzolytics IPF Immune™: CRN Data Shows Record-Breaking Number of Americans Use Dietary Supplements

More Released on March 29, 2022

CEO of Enzolytics IPF Immune™: Tips to Boost Your Immune System

More Released on March 25, 2022

Enzolytics IPF Immune™ Plans Debut at ECRM’s "Weight Management, Nutrition, and Vitamin Program"

More Released on February 28, 2022

Enzolytics CEO: Consumers Actively Searching For Immune Booster Supplements

More Released on February 24, 2022

Enzolytics IPF Immune™ is the Perfect Choice for People With Weakened Immune Systems

More Released on February 16, 2022